The diamond market spent the month resetting from both ends, and the July data leaves little room for spin. On the natural side, De Beers realized a consolidated average of $105 per carat in the second quarter, down 32% year over year. That decline arrived even as first-half production rose 46% to 14.914 million carats, and it landed against a Q2 rough sales figure of 7.1 million carats, down from 7.6 million a year earlier. More stones, weaker prices, thinner sell-through.

Set those three numbers next to each other and the picture is unambiguous. A 46% production jump paired with a sales figure that fell about 7% carat for carat means the producer put far more rough into the world than it moved, and it accepted a one-third haircut on price to clear even that reduced volume. For anyone reading the tape from a dealer floor, the sequence matters more than any single figure: supply expanded, price fell, and turnover still slipped. That is not a market finding a level, it is a market still looking for one.

De Beers pushed price to move goods

The sight mechanics told the same story. At its July sight, De Beers cut prices on certain smaller goods with decreases reaching 50% in some cases, and it held the event with a client list reportedly shorn by at least a third. Cutting price that hard on smaller goods while trimming the roster is a producer choosing volume and discipline over headline realization. The $105 average is the arithmetic result.

A 50% cut on smaller goods is not a promotional gesture, it is a repricing of the base of the pyramid. Melee and commercial goods are where the volume lives, and they are also where lab-grown competition bites hardest, so a producer defending the top of the book while surrendering the bottom is telling its sightholders exactly where it expects the pressure to stay. Shearing the client list by a third compounds the message: fewer buyers, each taking goods at prices that no longer pretend to hold last year's line. The remaining sightholders are being asked to move product, not to warehouse it.

For the trade, the read is that the producer is no longer defending the small-stone price at the cost of turnover. That reprices the melee and commercial-goods counter first, and it feeds straight into the retail conversations covered in this week's industry column, where an U.K. Tax on loose polished diamonds and precious-metal jewelry is set to land in August and add another cost layer at exactly the wrong moment.

Lab-grown set the floor lower again

The synthetic side kept sliding. The fair market price on a 1-carat lab-grown diamond stands at $770 as of July 2026, with most comparable stones listed between $654 and $810. The lowest-priced mainstream-quality 1-carat stone is available at $578. Over the past year, lab-grown prices have fallen 26.3%, a decline that shows no sign of finding a bottom while production capacity keeps expanding.

The band itself is the tell. A $654 to $810 range on a stone whose fair value is pegged at $770 is a spread of roughly 20% on the same nominal specification, which is what happens when supply outruns any pricing convention and every seller marks to whatever clears inventory that week. A 26.3% annual drop is steeper than anything on the natural side, and unlike rough, there is no producer with an incentive to hold a floor. Each new plant adds capacity to a product that gets cheaper as it scales, and the $578 print at the low end reads as a preview of where the middle of the band goes next.

The spread against natural is now the whole retail story. A natural 1-carat D/VVS2 retails around $4,600 in the U.S., while a lab-grown equivalent can be had for as low as $305 direct. That is not a discount, it is a different product category priced by a different logic, and the counter staff at every independent now has to explain it to a shopper who has already seen both numbers online. A ratio near 15 to 1 between the two on identical grading is not a gap a salesperson talks a customer across. It is a fork in the road, and the job at the case has shifted from selling a stone to defining two separate products.

The retail side is bracing

The pressure is reaching the storefront. Signet declared a $0.35 dividend with a July 24 ex-date even as its restructuring runs, a program that includes roughly 100 store closures and the shuttering of the James Allen banner. Returning cash while closing doors is the balancing act facing a specialty jeweler whose diamond-fashion mix sits right where the lab-grown price collapse hits hardest.

Closing about 100 doors while cutting a dividend check is a management team signaling to two audiences at once: to shareholders that the balance sheet still throws off cash, and to the trade that a store count built for one set of price points no longer fits the current one. Folding James Allen, an online-first diamond banner, at the same moment lab-grown drops to $305 direct is not a coincidence of timing. It is a specialty retailer conceding the segment where a manufactured stone at a fraction of natural's price has erased the margin.

The takeaway for anyone pricing a case this fall is that both ends moved against margin. Natural rough is cheaper because the producer chose to move it, and lab-grown is cheaper because supply keeps outrunning demand. The open question is whether the $105 De Beers realization marks the low for the cycle or simply the next step down, and the July sight suggests the producer is not betting on the former. The Swiss watch bounce covered in the watch column has no equivalent on the diamond counter yet: rough at $105 a carat and lab-grown at $770 for the one-carat stone are still the two numbers setting every price tag in the case.